For citations:
Gudz D.O., Krasnov A.E., Mamleev R.N., Kagirov R.K., Maximov M.L. Safety of Use of Russian Biosimilars of Interferon Beta-1b in the Treatment of Multiple Sclerosis: a Meta-analysis of Original Studies. Safety and Risk of Pharmacotherapy. 2019;7(2):93-98. (In Russ.) https://doi.org/10.30895/2312-7821-2019-7-2-93-98
Email this article 